Rune Labs key facts
as of Oct 2026- Developer of a medical platform designed to integrate with neuromodulation therapies to manage data ingestion, labelling, and availability.
- Rune Labs is valued at approximately $24.7M as of Oct 2026, set at its later-stage round, Jun 2025; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $57.4M across 6 recorded rounds; the latest was Early Stage VC ($11.2M) in Jun 2025.
- Notable investors include Samsung NEXT Ventures, 468 Capital, Village Global, City Light Capital, Eclipse Capital — 16 tracked in total.
- Rune Labs has filed 6 Form Ds with the SEC since 2019, most recently Jun 2025 ($11.2M sold to 20 investors).
- Status: Privately Held (backing).
Valued at $24.7M at its later-stage round, Jun 2025. Nothing has traded since.
- ·The complete investor list: 16 names
- ·Watch Rune Labs: the Monday email on marks, rounds and moves
Rune Labs funding rounds
6 roundsWho backs Rune Labs
16+Rune Labs valuation
Rune Labs was valued at $24.7 million at its later-stage round in Jun 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Rune Labs raised?
Rune Labs has raised $57.4 million across 6 recorded rounds since 2019. The largest was a $5 million seed round in Sep 2020; the most recent was an $11.2 million early-stage round in Jun 2025.
Rune Labs has filed 6 Form Ds with the SEC since 2019, most recently in Jun 2025 ($11.2 million sold to 20 investors).
Rune Labs investors
16 investors are on record for Rune Labs, including Samsung NEXT Ventures, 468 Capital, Village Global and City Light Capital. By type, the record holds 7 venture capital firms, 2 hedge funds and 1 family office. The early-stage round in Jun 2025 drew 20 investors.
About Rune Labs
Developer of a medical platform designed to integrate with neuromodulation therapies to manage data ingestion, labelling, and availability. The company's software platform helps partners in med-tech and pharma to ingest, organize, and analyze large amounts of brain input and output data, all on state-of-the-art secure cloud infrastructure, enabling clients to utilize data from new sensing and stim neuromodulation devices for therapy development and clinical and commercial closed-loop and adaptive therapy applications.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2018
- Employees
- 58
- Website
- runelabs.io/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.